Arrakis Bio
PrivateLast Round
Seed
Jul 19, 2023
Company Overview
Arrakis Bio is a biotechnology company that develops animal-free, high-quality human collagen and gelatin for medical, aesthetic, and biomedical applications.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arrakis Bio Comparables
Compare Arrakis Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Expansion Therapeutics | 89% | |
| Ribometrix | 88% | |
| xFOREST Therapeutics Co., Ltd. | 86% |
Arrakis Bio Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Arrakis Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FLORA Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 19, 2023
Seed round led by FLORA Ventures.
Arrakis Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Arrakis Bio's valuation, stock price, and market status.
Is Arrakis Bio a public or private company?
Arrakis Bio is a private company.
What is the current stock price of Arrakis Bio?
Arrakis Bio is a private company, so its shares have no public market price. Caplight tracks Arrakis Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arrakis Bio worth (valuation)?
Valuation information for Arrakis Bio is not publicly available.
Can I buy Arrakis Bio stock?
Arrakis Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arrakis Bio's last funding round?
Arrakis Bio's most recent funding round was Seed on July 19, 2023.
Who are the main investors in Arrakis Bio?
Key investors in Arrakis Bio include FLORA Ventures.
Will Arrakis Bio IPO soon?
No public IPO plans have been announced for Arrakis Bio.
How can I track Arrakis Bio secondary market activity?
Caplight tracks bids, offers, and trades in Arrakis Bio's shares on secondary markets.